These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8406274)

  • 1. [Mofebutazone--evaluation of possible interaction with glibenclamide].
    Speders S
    Fortschr Med; 1993 Aug; 111(22-23):366-8. PubMed ID: 8406274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactions of non-steroidal antirheumatic drugs with oral antidiabetic agents: acemetacin--glibenclamide].
    Haupt E; Hoppe FK; Rechziegler H; Zündorf P
    Z Rheumatol; 1987; 46(4):170-3. PubMed ID: 3118589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interactions between diclofenac and glibenclamide].
    Chlud K
    Z Rheumatol; 1976; 35(9-10):377-82. PubMed ID: 824884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interaction between chlorpropamide and non-steroidal anti-inflammatory drugs, ibuprofen and phenylbutazone.
    Shah SJ; Bhandarkar SD; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):470-2. PubMed ID: 6500764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative clinical study of a new antirheumatic agent, tolfenamic acid (Clotam), and phenylbutazone in rheumatoid arthritis.
    Nyfos L
    Scand J Rheumatol Suppl; 1979; (24):5-7. PubMed ID: 373085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of mofebutazone in asthmatic patients.
    Khayyal MT; El-Ghazaly M; El-Khatib AS; Hatem A
    Int J Clin Pharmacol Res; 1995; 15(4):145-51. PubMed ID: 8871264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis.
    Rejholec V; Vapaatalo H; Tokola O; Gothoni G
    Scand J Rheumatol Suppl; 1979; (24):13-6. PubMed ID: 373084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interaction: rifampicin and glibenclamide.
    Surekha V; Peter JV; Jeyaseelan L; Cherian AM
    Natl Med J India; 1997; 10(1):11-2. PubMed ID: 9069698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of mofebutazone in comparison to phenylbutazone on the adenosine triphosphate level of polymorphonuclear cells and their migration.
    Partsch G
    Arzneimittelforschung; 1992 Nov; 42(11):1336-8. PubMed ID: 1492846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.
    Massi-Benedetti M; Herz M; Pfeiffer C
    Horm Metab Res; 1996 Sep; 28(9):451-5. PubMed ID: 8911982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [4-prenyl-1,2-diphenyl-3,5-pyrazolidindione (DA 2370) in rheumatoid arthritis: clinical study with the use of a new weighted articular index].
    Cerri B; Bianchi G; Chierichetti S
    Reumatismo; 1972; 24(3):217-24. PubMed ID: 4549698
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes.
    Arnqvist HJ; Karlberg BE; Melander A
    Ann Clin Res; 1983; 15 Suppl 37():21-5. PubMed ID: 6433769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
    Domke A; Willms B
    Med Klin (Munich); 1994 Apr; 89(4):187-92. PubMed ID: 8015532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glibenclamide steady state plasma levels during concomitant vinpocetine administration in type II diabetic patients.
    Grandt R; Braun W; Schulz HU; Lührmann B; Frercks HJ
    Arzneimittelforschung; 1989 Nov; 39(11):1451-4. PubMed ID: 2515864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of feprazone for long-term treatment of rheumatoid arthritis and osteoarthritis.
    Bianchi G; Cerri B; Grasso S; Carazzi R; Dotti F; Ongari R; Cerrato O; Viara M
    Clin Ther; 1981; 3(5):349-55. PubMed ID: 7471130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.